Delafloxacin gets FDA priority review approval for community-acquired bacterial pneumonia | Speciality Medical Dialogues
https://speciality.medicaldialogues.in/delafloxacin-gets-fda-priority-review-approval-for-community-acquired-bacterial-pneumonia/Hospital-based sentinel surveillance for Streptococcus pneumoniae and other invasive bacterial diseases in India (HBSSPIBD): design and methodology. - PubMed - NCBI
https://www.ncbi.nlm.nih.gov/pubmed/32273315Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections
https://www.contagionlive.com/news/keith-s-kaye-md-mph-restoreimi-2-and-treating-critically-ill-patients-with-respiratory-infectionsAcinetobacterAmikacinAmpC cephalosporinaseBacteremiaBacterial pneumoniaCefepimeCiprofloxacinEnterobacteriaceaeExtended spectrum beta-lactamases (ESBL)GentamicinImipenemImipenem-cilastatin-relebactamKlebsiella pneumoniae carbapenemase (KPC)LevofloxacinLinezolidMeropenemPiperacillin-tazobactamPseudomonasRelebactamSepsisTobramycinVancomycin
Lefamulin Could Be Vital in the Pneumonia Fight | Drug Topics
https://www.drugtopics.com/latest/lefamulin-could-be-vital-pneumonia-fightStewardship / Resistance Scan for Oct 28, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-28-2019Treatment of Community-Acquired Pneumonia During the COVID-19 Pandemic | Annals of Internal Medicine | American College of Physicians
https://annals.org/aim/fullarticle/2766021/treatment-community-acquired-pneumonia-during-coronavirus-disease-2019-covid-19Unyvero HPN Panel Rapidly Identifies Bacterial Coinfections in COVID-19 Pneumonia - Infectious Disease Advisor
https://www.infectiousdiseaseadvisor.com/home/topics/covid19/unyvero-hpn-panel-detects-bacterial-coinfections-coronavirus-covid19-pneumonia/